Drugs / Lactobacillus farciminis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00852865 | Feb → Apr 2009 | — | Lallemand SAS | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus farciminis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00852865 ↗ |
| Modality | Other / unclassified | “a Probiotic (Lactobacillus Farciminis)” NCT00852865 ↗ |